Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Parathyroid Diseases 1Ovarian Neoplasms 1Neoplasms 1Melanoma 1Margins of Excision 1Inflammatory Breast Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Ovarian Epithelial 1Adenoma 1

Interventions

Cyclophosphamide 3fludarabine 2Paclitaxel 2Carboplatin 2Bevacizumab 2trastuzumab deruxtecan 1pembrolizumab 1olaparib 1niraparib 1mirvetuximab soravtansine 1irinotecan sucrosofate 1fludarabine phosphate 1denileukin diftitox 1Tinzaparin 1Propranolol 1Palliative Care 1Nivolumab 1Neoadjuvant Therapy 1Music Therapy 1Losartan 1Indocyanine Green 1GEN-1 1Etodolac 1E7777 fusion protein 1Clarithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Indocyanine Green × 30 days × Clear all
NCT07593339 2026-05-18

Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery

Başakşehir Çam & Sakura City Hospital

Phase NA Not yet recruiting
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡